Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Propyl gallate

Propyl gallate

121-79-9

DISCOVER
PROPYL PARAHYDROXYBENZOATE CRS (150 MG)

PROPYL PARAHYDROXYBENZOATE CRS (150 MG)

94-13-3

DISCOVER
Piperine

Piperine

94-62-2

DISCOVER
PROPYLTHIOURACIL CRS (30 MG)

PROPYLTHIOURACIL CRS (30 MG)

51-52-5

DISCOVER
Propafenone HCl

Propafenone HCl

34183-22-7

DISCOVER
PROPYPHENAZONE CRS (200 MG)

PROPYPHENAZONE CRS (200 MG)

479-92-5

DISCOVER
PROTIRELIN CRS (5.03 MG)

PROTIRELIN CRS (5.03 MG)

24305-27-9

DISCOVER
D-HIS-PROTIRELIN CRS (0.1 MG)

D-HIS-PROTIRELIN CRS (0.1 MG)

NA

DISCOVER
PROXYPHYLLINE CRS (100 MG)

PROXYPHYLLINE CRS (100 MG)

603-00-9

DISCOVER
PSEUDOEPHEDRINE HYDROCHLORIDECRS - * DRUG PRECURSOR (50 MG)

PSEUDOEPHEDRINE HYDROCHLORIDECRS - * DRUG PRECURSOR (50 MG)

345-78-8

DISCOVER
PURPUREAGLYCOSIDE A CRS (25 MG)

PURPUREAGLYCOSIDE A CRS (25 MG)

19855-40-4

DISCOVER
Propofol Impurity 29

Propofol Impurity 29

83237-15-4

DISCOVER